CoChat

Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy

Open access

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Iron-sulfur (Fe-S) clusters are ubiquitous cofactors essential to various cellular processes, including mitochondrial respiration, DNA repair, and iron homeostasis. A steadily increasing number of disorders are being associated with disrupted biogenesis of Fe-S clusters. Here, we conducted whole-exome sequencing of patients with optic atrophy and other neurological signs of mitochondriopathy and identified 17 individuals from 13 unrelated families with recessive mutations in FDXR, encoding the mitochondrial membrane-associated flavoprotein ferrodoxin reductase required for electron transport from NADPH to cytochrome P450. In vitro enzymatic assays in patient fibroblast cells showed deficient ferredoxin NADP reductase activity and mitochondrial dysfunction evidenced by low oxygen consumption rates (OCRs), complex activities, ATP production and increased reactive oxygen species (ROS). Such defects were rescued by overexpression of wild-type FDXR. Moreover, we found that mice carrying a spontaneous mutation allelic to the most common mutation found in patients displayed progressive gait abnormalities and vision loss, in addition to biochemical defects consistent with the major clinical features of the disease. Taken together, these data provide the first demonstration that germline, hypomorphic mutations in FDXR cause a novel mitochondriopathy and optic atrophy in humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddx377

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Pedigree of affected families, eye phenotypes, and FDXR mutations. (A) Family pedigrees. Filled symbols represent affected individuals. Biallelic FDXR variants are indicated with each pedigree. (B) Schematic representation of FDXR and its predicted protein product. Exons are represented with boxes. The NAD(P) and FAD/NAD(P) binding domains are shown in orange and green, respectively, and the observed mutations are labelled. Figure was generated using Illustrator for Biological Sciences (IBS), available at http://ibs.biocuckoo.org/index.php as described previously (44). MTP: Mitochondrial Transit Peptide or mitochondrial targeting signals. (C) Retinal image of optic atrophy from a patient with a compound heterozygous FDXR mutation (p.F51L/p.G443S). (D) Patient mutations mapped to a three-dimensional FDXR structure, based on the homologous FDXR structure (starting from blue at the N-terminal region, and ending at red in the C-terminus) for Bos taurus complexed with FAD (gold). The residue position of missense variants and starting point of truncations are indicated with red spheres.
Figure 1. Pedigree of affected families, eye phenotypes, and FDXR mutations. (A) Family pedigrees. Filled symbols represent affected individuals. Biallelic FDXR variants are indicated with each pedigree. (B) Schematic representation of FDXR and its predicted protein product. Exons are represented with boxes. The NAD(P) and FAD/NAD(P) binding domains are shown in orange and green, respectively, and the observed mutations are labelled. Figure was generated using Illustrator for Biological Sciences (IBS), available at http://ibs.biocuckoo.org/index.php as described previously (44). MTP: Mitochondrial Transit Peptide or mitochondrial targeting signals. (C) Retinal image of optic atrophy from a patient with a compound heterozygous FDXR mutation (p.F51L/p.G443S). (D) Patient mutations mapped to a three-dimensional FDXR structure, based on the homologous FDXR structure (starting from blue at the N-terminal region, and ending at red in the C-terminus) for Bos taurus complexed with FAD (gold). The residue position of missense variants and starting point of truncations are indicated with red spheres.CC BY-NC · PubMed Central
Figure 2. FDXR protein levels in patient fibroblasts are decreased relative to control cells. (A) Comparison of western blot results showed lower levels of FDXR expression in patient fibroblasts compared with control fibroblasts. (B) Quantification data of bands intensity was performed. Data are representative of three independent replications. (C) 3 D images evaluated by confocal microscopy using a Nikon AIR LUN-V Inverted confocal microscope and analyzed by Imaris software. (D) 2 D images evaluated by confocal microscopy using a Nikon AIR LUN-V Inverted confocal microscope and analyzed by Imaris software. The antibody we used was obtained from abcam (ab204310). The recombinant fragment corresponding to Human Ferredoxin Reductase is from aa 1 to aa 134.
Figure 2. FDXR protein levels in patient fibroblasts are decreased relative to control cells. (A) Comparison of western blot results showed lower levels of FDXR expression in patient fibroblasts compared with control fibroblasts. (B) Quantification data of bands intensity was performed. Data are representative of three independent replications. (C) 3 D images evaluated by confocal microscopy using a Nikon AIR LUN-V Inverted confocal microscope and analyzed by Imaris software. (D) 2 D images evaluated by confocal microscopy using a Nikon AIR LUN-V Inverted confocal microscope and analyzed by Imaris software. The antibody we used was obtained from abcam (ab204310). The recombinant fragment corresponding to Human Ferredoxin Reductase is from aa 1 to aa 134.CC BY-NC · PubMed Central
Figure 3. Mitochondrial dysfunction in patient fibroblasts. (A) Enzymatic assay of ferredoxin NADP reductase in fibroblasts (includes all products with a specification for this enzyme). Reductase activity was normalized relative to control fibroblasts. (B) An analysis of O2 consumption in indicated cell lines. OCRs were first measured for 1 × 104 cells/sample under basal conditions, and then measured repeatedly following the sequential addition of oligomycin (1.5 μM), carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP) (4 μM), rotenone (1 μM), and antimycin A (1 μM) at the indicated times. (C) Basal, ATP-linked, maximal, and reserve capacity OCR in mutant and control cell lines. Basal OCR is OCR before the addition of oligomycin minus OCR after the addition of rotenone/antimycin A. ATP-linked OCR is OCR before the addition of oligomycin minus OCR after the addition of oligomycin. Maximal OCR is OCR after the addition of FCCP minus non-mitochondrial OCR. Reserve capacity OCR is the difference between maximal OCR after the addition of FCCP and basal OCR. (D) Measurement of cellular and mitochondrial ATP levels in fibroblasts by bioluminescence assay. Average ATP levels (6–7 replicates per cell line) are shown as a percentage of control levels. (E) Enzymatic activities of respiratory chain complexes I, II, III and IV. The calculations were based on three independent determinations. Data are represented as the means ± SEM; *P<0.05, **P <0.01, ***P <0.001 vs. control, as determined by Student’s t test.
Figure 3. Mitochondrial dysfunction in patient fibroblasts. (A) Enzymatic assay of ferredoxin NADP reductase in fibroblasts (includes all products with a specification for this enzyme). Reductase activity was normalized relative to control fibroblasts. (B) An analysis of O2 consumption in indicated cell lines. OCRs were first measured for 1 × 104 cells/sample under basal conditions, and then measured repeatedly following the sequential addition of oligomycin (1.5 μM), carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP) (4 μM), rotenone (1 μM), and antimycin A (1 μM) at the indicated times. (C) Basal, ATP-linked, maximal, and reserve capacity OCR in mutant and control cell lines. Basal OCR is OCR before the addition of oligomycin minus OCR after the addition of rotenone/antimycin A. ATP-linked OCR is OCR before the addition of oligomycin minus OCR after the addition of oligomycin. Maximal OCR is OCR after the addition of FCCP minus non-mitochondrial OCR. Reserve capacity OCR is the difference between maximal OCR after the addition of FCCP and basal OCR. (D) Measurement of cellular and mitochondrial ATP levels in fibroblasts by bioluminescence assay. Average ATP levels (6–7 replicates per cell line) are shown as a percentage of control levels. (E) Enzymatic activities of respiratory chain complexes I, II, III and IV. The calculations were based on three independent determinations. Data are represented as the means ± SEM; *P<0.05, **P <0.01, ***P <0.001 vs. control, as determined by Student’s t test.CC BY-NC · PubMed Central
Figure 4. Increased ROS production in patient fibroblasts. (A) Profiling of ROS formation in fibroblasts loaded with ROS/superoxide detection reagents and untreated by pyocyanin or NAC. (B) Profiling of ROS formation by fluorescence microscopy in fibroblasts loaded with ROS/superoxide detection reagents and treated with pyocyanin. General oxidative stress levels were monitored in the green channel, while superoxide production was detected in the orange channel. (C) Quantification data of the relative positive signal ratio were performed after the cells were treated with pyocyanin. Data collected from 10 images for each group).
Figure 4. Increased ROS production in patient fibroblasts. (A) Profiling of ROS formation in fibroblasts loaded with ROS/superoxide detection reagents and untreated by pyocyanin or NAC. (B) Profiling of ROS formation by fluorescence microscopy in fibroblasts loaded with ROS/superoxide detection reagents and treated with pyocyanin. General oxidative stress levels were monitored in the green channel, while superoxide production was detected in the orange channel. (C) Quantification data of the relative positive signal ratio were performed after the cells were treated with pyocyanin. Data collected from 10 images for each group).CC BY-NC · PubMed Central
Figure 5. Mitochondrial function in mouse muscle and brain tissues. (A) Results of the Ferredoxin NADP reductase activity assay (all enzyme-specific products) in mouse tissues. Relative activity levels were normalized relative to levels in WT mice. (B) Quantitative bioluminescence assay of cellular and mitochondrial ATP levels. (C) Activities of respiratory chain complexes I, II, III and IV in mitochondria isolated from three mutant mouse tissues and three WT mouse tissues. The calculations were based on four independent determinations.
Figure 5. Mitochondrial function in mouse muscle and brain tissues. (A) Results of the Ferredoxin NADP reductase activity assay (all enzyme-specific products) in mouse tissues. Relative activity levels were normalized relative to levels in WT mice. (B) Quantitative bioluminescence assay of cellular and mitochondrial ATP levels. (C) Activities of respiratory chain complexes I, II, III and IV in mitochondria isolated from three mutant mouse tissues and three WT mouse tissues. The calculations were based on four independent determinations.CC BY-NC · PubMed Central
Figure 6. Visual acuity defects associated with loss of retinal ganglion cells (RGCs) and abnormal myelination of optic nerve in 6-month-old mice with p.R389Q/R389Q mutations. (A) Ability to track directionality of visual cues (black and white lines) in real time via closed circuit camera monitoring was assessed. Frequency thresholds were measured by systematically increasing the spatial frequency of the gratings (narrowing of stripes) at 100% contrast until animals could no longer track (45) and optokinetic scores were calculated. FdxrR389Q/R389Q showed significantly impaired visual acuity compared with age and sex-matched controls. (B) H&E-stained sagittal sections through the optic disc of eyes showed that the number of retinal ganglion cell (RGC) layer nuclei was reduced in H&E sections of eyes from 6-month-old p.R389Q mice as compared with WT control mice. Nuclei (excluding the flat and smaller endothelial nuclei) were counted in the RGC layer in H&E sections (D). Nuclear number in the RGC layer of p.R389Q mice decreased significantly (B and D). (C) Transmission electron microscopy (TEM) showed a significant decrease in the thickness of the myelin sheath of RGC axons in 6-month-old p.R389Q mice. Compared with WT RGC axons, RGC axons of p.R389Q mice lost their myelin sheath (C); the reduction in the thickness of the myelin sheath of p.R392Q RGC axons was statistically significant (E). Thickness of the myelin sheath of the RGC axons in the optic nerve was also measured using ImageJ software (E). (F) TEM study of the 6-month-old retina indicated that the p.R389Q mice had a clear reduction in the number of their RGCs; the remaining RGCs also showed an empty cytoplasm, shrinkage of the nuclei, and aggregation of chromatin inside the nuclei (F, arrow).
Figure 6. Visual acuity defects associated with loss of retinal ganglion cells (RGCs) and abnormal myelination of optic nerve in 6-month-old mice with p.R389Q/R389Q mutations. (A) Ability to track directionality of visual cues (black and white lines) in real time via closed circuit camera monitoring was assessed. Frequency thresholds were measured by systematically increasing the spatial frequency of the gratings (narrowing of stripes) at 100% contrast until animals could no longer track (45) and optokinetic scores were calculated. FdxrR389Q/R389Q showed significantly impaired visual acuity compared with age and sex-matched controls. (B) H&E-stained sagittal sections through the optic disc of eyes showed that the number of retinal ganglion cell (RGC) layer nuclei was reduced in H&E sections of eyes from 6-month-old p.R389Q mice as compared with WT control mice. Nuclei (excluding the flat and smaller endothelial nuclei) were counted in the RGC layer in H&E sections (D). Nuclear number in the RGC layer of p.R389Q mice decreased significantly (B and D). (C) Transmission electron microscopy (TEM) showed a significant decrease in the thickness of the myelin sheath of RGC axons in 6-month-old p.R389Q mice. Compared with WT RGC axons, RGC axons of p.R389Q mice lost their myelin sheath (C); the reduction in the thickness of the myelin sheath of p.R392Q RGC axons was statistically significant (E). Thickness of the myelin sheath of the RGC axons in the optic nerve was also measured using ImageJ software (E). (F) TEM study of the 6-month-old retina indicated that the p.R389Q mice had a clear reduction in the number of their RGCs; the remaining RGCs also showed an empty cytoplasm, shrinkage of the nuclei, and aggregation of chromatin inside the nuclei (F, arrow).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

See all 64

Metadata

Authors
Peng, Y., Shinde, D. N., Valencia, C. A., Mo, J.-S., Rosenfeld, J., Truitt Cho, M., Chamberlin, A., Li, Z., Liu, J., Gui, B., Brockhage, R., Basinger, A., Alvarez-Leon, B., Heydemann, P., Magoulas, P. L., Lewis, A. M., Scaglia, F., Gril, S., Chong, S. C., Bower, M., Monaghan, K. G., Willaert, R., Plona, M.-R., Dineen, R., Milan, F., Hoganson, G., Powis, Z., Helbig, K. L., Keller-Ramey, J., Harris, B., Anderson, L. C., Green, T., Sukoff Rizzo, S. J., Kaylor, J., Chen, J., Guan, M.-X., Sellars, E., Sparagana, S. P., Gibson, J. B., Reinholdt, L. G., Tang, S., & Huang, T.
Affiliations
  • Cincinnati Children's Hospital Medical Center (US)
  • Ambry Genetics (United States) (US)
  • Baylor College of Medicine (US)
  • GeneDx Inc., Gaithersburg, MD 20877, USA
  • Cook Children's Medical Center (US)
  • Rush University Medical Center (US)
  • Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (AR)
  • Chinese University of Hong Kong (HK)
  • University of Minnesota Medical Center (US)
  • University of Illinois Chicago (US)
  • Pediatric Genetics, University of Illinois at Chicago, Chicago, IL 60607, USA
  • Clinical Genomics, Ambry Genetics, Aliso Viejo, CA 92656, USA
  • Jackson Laboratory (US)
  • The Jackson Laboratory, Bar Harbor, ME 04609, USA
  • Arkansas Children's Hospital (US)
  • University of Oklahoma Health Sciences Center (US)
  • Zhejiang University (CN)
  • Texas Scottish Rite Hospital for Children (US)
  • Dell Children's Medical Center of Central Texas (US)
Corresponding author
Huang, Taosheng
Venue
Human Molecular Genetics
Published
2017-10-05
Volume
26
Issue
24
Pages
4937-4950
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2763842705
Cited by
60
References
45
Citations by year
2026: 9 · 2025: 8 · 2024: 7 · 2023: 4 · 2022: 8 · 2021: 9 · 2020: 7 · 2019: 2 · 2018: 5
FWCI
1.56
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Human Molecular Genetics (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
Funders
Jackson Laboratory
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Metalloenzymes and iron-sulfur proteins
Keywords
ferredoxin reductase, mitochondrial disease, optic atrophy, iron-sulfur cluster assembly, biallelic variants, hypomorphic mutation, mitochondrial dysfunction, reactive oxygen species, gait disturbance, vision loss, mouse model
MeSH terms
Exome Sequencing, Adolescent, Alleles, Animals, Child, Child, Preschool, Electron Transport, Female, Ferredoxins, Humans, Infant, Iron, Iron-Sulfur Proteins, Male, Mitochondria, Mutation, Optic Atrophy, Oxidoreductases, Pedigree, Mutagenesis, Sulfite Reductase (Ferredoxin), Mitochondrial Membranes, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy. https://app.cochat.ai/papers/10.1093/hmg/ddx377
The paper
Peng, Y., Shinde, D. N., Valencia, C. A., Mo, J.-S., Rosenfeld, J., Truitt Cho, M., Chamberlin, A., Li, Z., Liu, J., Gui, B., Brockhage, R., Basinger, A., Alvarez-Leon, B., Heydemann, P., Magoulas, P. L., Lewis, A. M., Scaglia, F., Gril, S., Chong, S. C., . . . Huang, T. (2017). Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddx377

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.